196 related articles for article (PubMed ID: 26552420)
1. Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study.
Maritschnegg E; Wang Y; Pecha N; Horvat R; Van Nieuwenhuysen E; Vergote I; Heitz F; Sehouli J; Kinde I; Diaz LA; Papadopoulos N; Kinzler KW; Vogelstein B; Speiser P; Zeillinger R
J Clin Oncol; 2015 Dec; 33(36):4293-300. PubMed ID: 26552420
[TBL] [Abstract][Full Text] [Related]
2. Towards less invasive molecular diagnostics for endometrial cancer: massively parallel sequencing of endometrial lavage specimens in women attending for an office hysteroscopy.
Chao A; Wu KY; Lin CY; Lee YS; Huang HJ; Tang YH; Weng CH; Chao AS; Chang TC; Lai CH; Wu RC
J Mol Med (Berl); 2022 Sep; 100(9):1331-1339. PubMed ID: 35953603
[TBL] [Abstract][Full Text] [Related]
3. Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
Nair N; Camacho-Vanegas O; Rykunov D; Dashkoff M; Camacho SC; Schumacher CA; Irish JC; Harkins TT; Freeman E; Garcia I; Pereira E; Kendall S; Belfer R; Kalir T; Sebra R; Reva B; Dottino P; Martignetti JA
PLoS Med; 2016 Dec; 13(12):e1002206. PubMed ID: 28027320
[TBL] [Abstract][Full Text] [Related]
4. Uterine Cavity Lavage Mutation Analysis in Lithuanian Ovarian Cancer Patients.
Žilovič D; Vaicekauskaitė I; Čiurlienė R; Sabaliauskaitė R; Jarmalaitė S
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765826
[TBL] [Abstract][Full Text] [Related]
5. Uterine lavage identifies cancer mutations and increased
Ghezelayagh TS; Kohrn BF; Fredrickson J; Manhardt E; Radke MR; Katz R; Gray HJ; Urban RR; Pennington KP; Liao JB; Doll KM; Simons EJ; Burzawa JK; Goff BA; Speiser P; Swisher EM; Norquist BM; Risques RA
Cancer Res Commun; 2022 Oct; 2(10):1282-1292. PubMed ID: 36311816
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
7. Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept study.
Mayo-de-Las-Casas C; Velasco A; Sanchez D; Martínez-Bueno A; Garzón-Ibáñez M; Gatius S; Ruiz-Miró M; Gonzalez-Tallada X; Llordella I; Tresserra F; Rodríguez S; Aldeguer E; Roman-Canal B; Bertran-Alamillo J; García-Peláez B; Rosell R; Molina-Vila MA; Matias-Guiu X
Int J Cancer; 2020 Jul; 147(1):277-284. PubMed ID: 31953839
[TBL] [Abstract][Full Text] [Related]
8. KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system.
Sadlecki P; Antosik P; Grzanka D; Grabiec M; Walentowicz-Sadlecka M
Tumour Biol; 2017 Oct; 39(10):1010428317733984. PubMed ID: 28992761
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic potential of c-erbB-2 and its association with c-K-ras in premalignant and malignant lesions of the human uterine endometrium.
Manavi M; Bauer M; Baghestanian M; Berger A; Kucera E; Pischinger K; Battistutti W; Czerwenka K
Tumour Biol; 2001; 22(5):299-309. PubMed ID: 11553860
[TBL] [Abstract][Full Text] [Related]
10. The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.
Ketabi Z; Gerdes AM; Mosgaard B; Ladelund S; Bernstein I
Gynecol Oncol; 2014 Jun; 133(3):526-30. PubMed ID: 24631699
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies.
Ross JS; Ali SM; Wang K; Palmer G; Yelensky R; Lipson D; Miller VA; Zajchowski D; Shawver LK; Stephens PJ
Gynecol Oncol; 2013 Sep; 130(3):554-9. PubMed ID: 23791828
[TBL] [Abstract][Full Text] [Related]
12. Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy.
Martignetti JA; Pandya D; Nagarsheth N; Chen Y; Camacho O; Tomita S; Brodman M; Ascher-Walsh C; Kolev V; Cohen S; Harkins TT; Schadt EE; Reva B; Sebra R; Dottino P
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30301868
[TBL] [Abstract][Full Text] [Related]
13. Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
Meagher NS; Schuster K; Voss A; Budden T; Pang CNI; deFazio A; Ramus SJ; Friedlander ML
Gynecol Oncol; 2018 Sep; 150(3):527-533. PubMed ID: 30054102
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients.
Zhang L; Luo M; Yang H; Zhu S; Cheng X; Qing C
J Ovarian Res; 2019 Feb; 12(1):19. PubMed ID: 30786925
[TBL] [Abstract][Full Text] [Related]
15. Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor.
Fujiwara S; Nawa A; Nakanishi T; Shimoyama Y; Kajiyama H; Shibata K; Ino K; Nakamura S; Kikkawa F; Yatabe Y
Hum Pathol; 2010 Apr; 41(4):560-5. PubMed ID: 20004952
[TBL] [Abstract][Full Text] [Related]
16. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Kinde I; Bettegowda C; Wang Y; Wu J; Agrawal N; Shih IeM; Kurman R; Dao F; Levine DA; Giuntoli R; Roden R; Eshleman JR; Carvalho JP; Marie SK; Papadopoulos N; Kinzler KW; Vogelstein B; Diaz LA
Sci Transl Med; 2013 Jan; 5(167):167ra4. PubMed ID: 23303603
[TBL] [Abstract][Full Text] [Related]
18. Identification of Somatic Mutations in Papanicolaou Smear DNA and Plasma Circulating Cell-Free DNA for Detection of Endometrial and Epithelial Ovarian Cancers: A Pilot Study.
Jiang X; Li W; Yang J; Wang S; Cao D; Yu M; Shen K; Bai J; Gao Y
Front Oncol; 2020; 10():582546. PubMed ID: 33381450
[TBL] [Abstract][Full Text] [Related]
19. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia.
Zauber P; Denehy TR; Taylor RR; Ongcapin EH; Marotta S; Sabbath-Solitare M
Int J Gynecol Cancer; 2015 Jun; 25(5):863-8. PubMed ID: 25768080
[TBL] [Abstract][Full Text] [Related]
20. Synchronous ovarian and endometrial cancer--an international multicenter case-control study.
Heitz F; Amant F; Fotopoulou C; Battista MJ; Wimberger P; Traut A; Fisseler-Eckhoff A; Harter P; Vandenput I; Sehouli J; Schmidt M; Kimmig R; du Bois R; du Bois A
Int J Gynecol Cancer; 2014 Jan; 24(1):54-60. PubMed ID: 24300466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]